First-in-Class vs Me-Too Launch Differences and the Role of Content, Hyperpersonalization, and Technology with Frank Dolan, Founder and CEO of ARSENAL
Pharma Launch Secrets
00:00
How to Get the Attention of Providers That Say Yes to Virtual Calls
If we have a fair amount of virtual calls that look to be a permanent part of our future, how do you get the attention of providers? If I don't know this drug ... why should I say yes to that calendar hold? And then the third layer of complexities is if we have access problems.
Transcript
Play full episode
